Smotherman C, Sprague B, Braithwaite D, Yaghjyan L
Am J Cancer Res. 2025; 14(12):5935-5951.
PMID: 39803660
PMC: 11711532.
DOI: 10.62347/WNIY6250.
Yu J, Wang C
Front Oncol. 2023; 13:1047336.
PMID: 36761956
PMC: 9903134.
DOI: 10.3389/fonc.2023.1047336.
Chiarella P, Capone P, Sisto R
Int J Environ Res Public Health. 2023; 20(2).
PMID: 36673670
PMC: 9858723.
DOI: 10.3390/ijerph20020912.
Meng X, Wang X, Zhang X, Zhang C, Zhang Z, Zhang K
Cells. 2022; 11(9).
PMID: 35563727
PMC: 9100007.
DOI: 10.3390/cells11091421.
Ozoran E, Trabulus F, Erhan D, Batar B, Guven M
Int J Breast Cancer. 2022; 2022:5817841.
PMID: 35320970
PMC: 8938079.
DOI: 10.1155/2022/5817841.
Associations between XRCC3 Thr241Met polymorphisms and breast cancer risk: systematic-review and meta-analysis of 55 case-control studies.
Dashti S, Taherian-Esfahani Z, Keshtkar A, Ghafouri-Fard S
BMC Med Genet. 2019; 20(1):79.
PMID: 31077156
PMC: 6511159.
DOI: 10.1186/s12881-019-0809-8.
Cytogenetic effects of radiation and genetic polymorphisms of the XRCC1 and XRCC3 repair genes in industrial radiographers.
Shakeri M, Zakeri F, Changizi V, Rajabpour M, Farshidpour M
Radiat Environ Biophys. 2019; 58(2):247-255.
PMID: 30955049
DOI: 10.1007/s00411-019-00782-5.
Polymorphisms in BER genes and risk of breast cancer: evidences from 69 studies with 33760 cases and 33252 controls.
Qiao L, Feng X, Wang G, Zhou B, Yang Y, Li M
Oncotarget. 2018; 9(22):16220-16233.
PMID: 29662639
PMC: 5882330.
DOI: 10.18632/oncotarget.23804.
DNA Repair Mechanism Gene, XRCC1A ( Arg194Trp) but not XRCC3 ( Thr241Met) Polymorphism Increased the Risk of Breast Cancer in Premenopausal Females: A Case-Control Study in Northeastern Region of India.
Devi K, Ahmed J, Narain K, Mukherjee K, Majumdar G, Chenkual S
Technol Cancer Res Treat. 2018; 16(6):1150-1159.
PMID: 29332455
PMC: 5762082.
DOI: 10.1177/1533034617736162.
Genetic Variations of DNA Repair Genes in Breast Cancer.
Ozgoz A, Hekimler Ozturk K, Yukselturk A, Samli H, Baskan Z, Mutlu Icduygu F
Pathol Oncol Res. 2017; 25(1):107-114.
PMID: 28983784
DOI: 10.1007/s12253-017-0322-3.
A rare FANCA gene variation as a breast cancer susceptibility allele in an Iranian population.
Abbasi S, Rasouli M
Mol Med Rep. 2017; 15(6):3983-3988.
PMID: 28440412
PMC: 5436159.
DOI: 10.3892/mmr.2017.6489.
Polymorphism of the XRCC1 Gene Is Associated with Susceptibility and Short-Term Recovery of Ischemic Stroke.
He W, Huang P, Liu D, Zhong L, Yu R, Li J
Int J Environ Res Public Health. 2016; 13(10).
PMID: 27763529
PMC: 5086755.
DOI: 10.3390/ijerph13101016.
XRCC1 and OGG1 Gene Polymorphisms and Breast Cancer: A Systematic Review of Literature.
Moghaddam A, Nazarzadeh M, Noroozi R, Darvish H, Mosavi Jarrahi A
Iran J Cancer Prev. 2016; 9(1):e3467.
PMID: 27366307
PMC: 4922200.
DOI: 10.17795/ijcp-3467.
Association of XRCC1 Trp194 allele with risk of breast cancer, and Ki67 protein status in breast tumor tissues.
Jalali C, Ghaderi B, Amini S, Abdi M, Roshani D
Saudi Med J. 2016; 37(6):624-30.
PMID: 27279507
PMC: 4931642.
DOI: 10.15537/Smj.2016.6.13540.
Association between XRCC3 Thr241Met Polymorphism and Risk of Breast Cancer: Meta-Analysis of 23 Case-Control Studies.
Chai F, Liang Y, Chen L, Zhang F, Jiang J
Med Sci Monit. 2015; 21:3231-40.
PMID: 26498491
PMC: 4627365.
DOI: 10.12659/msm.894637.
X-ray repair cross-complementing protein 1 and 3 polymorphisms and susceptibility of breast cancer in a Jordanian population.
Zoubi M
Saudi Med J. 2015; 36(10):1163-7.
PMID: 26446325
PMC: 4621720.
DOI: 10.15537/smj.2015.10.12659.
XRCC1 R399Q polymorphism and colorectal cancer risk in the Chinese Han population: a meta-analysis.
Qin C, Xu K, Chen Z, Zhai E, He Y, Song X
Tumour Biol. 2015; 36(2):461-6.
PMID: 25582318
DOI: 10.1007/s13277-015-3054-6.
Association between the XRCC1 Arg194Trp polymorphism and risk of cancer: evidence from 201 case-control studies.
Feng Y, Liu Y, He X, Wei W, Shen X, Xie D
Tumour Biol. 2014; 35(11):10677-97.
PMID: 25064613
DOI: 10.1007/s13277-014-2326-x.
XRCC1 Arg399Gln polymorphism confers risk of breast cancer in American population: a meta-analysis of 10846 cases and 11723 controls.
Bu T, Liu L, Sun Y, Zhao L, Peng Y, Zhou S
PLoS One. 2014; 9(1):e86086.
PMID: 24489692
PMC: 3904848.
DOI: 10.1371/journal.pone.0086086.
XRCC1 Arg399Gln genetic polymorphism and the risk of hepatocellular carcinoma: a meta-analysis.
Qi Y, Cui L, Song Y, Li N
Mol Biol Rep. 2014; 41(2):879-87.
PMID: 24390232
DOI: 10.1007/s11033-013-2929-0.